Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.
Jennifer L LeddonShuchi GulatiSulsal HaqueCasey AllenSarah PalackdharryMaria MathewsNicky KurtzweilMuhammed Kashif RiazVinita TakiarMisako NagasakaYash PatilChad ZenderAlice TangBrian CervenkaJulie McGrathWolfgang Michael KornBenjamin H HinrichsRoman JandarovNusrat HarunAmmar SukariTrisha Michel Wise-DraperPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Adjuvant nivolumab after salvage surgery in locally recurrent HNSCC is well tolerated and showed improved DFS compared with historical controls.